Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 Oct 31;136(3):837–845. doi: 10.1007/s10549-012-2308-x

Table 2.

Adjusted odds ratio (OR) and 95% confidence intervals (CI) for postmenopausal breast cancer by plasma MMP levels

Geometric Mean (pg/ml)
(Mean±SD)
Across 2 SD of the
log-transformed
MMP values b
Quartiles (Q) d

Q1 Q2 Q3 Q4






Cases
(n=713)
Controls
(n=713)
P-value a OR (95% CI) c OR OR (95% CI) c OR (95% CI) c OR (95% CI) c Ptrendc,e
MMP-1 81.7±0.81 78.7±0.82 0.37 1.07 (0.93 – 1.23) 1.00 0.80 (0.59 – 1.09) 0.93 (0.70 – 1.25) 1.04 (0.77 – 1.41) 0.32
MMP-2 20.4±1.79 20.5±0.21 0.58 0.82 (0.44 – 1.53) 1.00 1.06 (0.78 – 1.42) 0.87 (0.63 – 1.20) 0.87 (0.63 – 1.21) 0.53
MMP-3 1.22±0.46 1.22±0.49 0.86 0.93 (0.62 – 1.39) 1.00 1.01 (0.74 – 1.37) 0.97 (0.71 – 1.32) 1.02 (0.75 – 1.38) 0.72
MMP-7 167.0±0.63 163.4±0.68 0.50 1.04 (0.87 – 1.25) 1.00 1.07 (0.79 – 1.47) 1.07 (0.78 – 1.47) 1.00 (0.72 – 1.39) 0.64

Abbreviation: MMP, matrix metalloproteinase; SD, standard deviation.

a

P-value for the difference between cases and controls based on paired t-test.

b

Two SD of the log-transformed MMPs: 1.60 for MMP-1; 0.37 for MMP-2; 0.55 for MMP-3; 1.29 for MMP-7.

c

Modeled through conditional logistic regression after adjustment for body mass index, number of live births, and family history of breast cancer.

d

Medians for the quartiles: 3.53, 4.14, .4.59, 5.27 for MMP-1; 2.88, 3.02, 3.12, 3.25 for MMP-2; 0.56, 0.72, 0.86, 1.09 for MMP-3; 4.51, 4.92, 5.25, 5.71 for MMP-7.

e

P value for the continuous log-transformed MMP level.